| dc.contributor | Departament de Salut |
| dc.contributor.author | Casabona, Jordi |
| dc.contributor.author | Brugal, Teresa |
| dc.contributor.author | Major Roca, Xavier |
| dc.contributor.author | Meroño, Mercè |
| dc.contributor.author | Espelt, Albert |
| dc.contributor.author | González, Victoria |
| dc.contributor.author | Grupo Redan |
| dc.contributor.author | Folch, Cinta |
| dc.date.accessioned | 2022-03-15T11:10:27Z |
| dc.date.available | 2022-03-15T11:10:27Z |
| dc.date.issued | 2012-01 |
| dc.identifier.citation | Folch C, Casabona J, Brugal MT, Majó X, Meroño M, Espelt A, et al. Perfil de los usuarios de drogas por vía parenteral que mantienen conductas de riesgo relacionadas con la inyección en Cataluña. Gac Sanit. Jan-Feb 2012;26(1):37-44. |
| dc.identifier.issn | 1578-1283 |
| dc.identifier.uri | https://hdl.handle.net/11351/7183 |
| dc.description | Drug injection; VIH; Harm reduction centers |
| dc.description.abstract | Objectives: To estimate the prevalence of direct and indirect syringe sharing among intravenous drug users (IDUs) attending a harm reduction center in Catalonia (Spain) and to identify factors associated with risk behaviors.
Methods: A cross-sectional study was conducted between 2008 and 2009 in harm reduction centers. Behavioral data were collected using anonymous questionnaires administered by trained interviewers.
Results: Of the 748 respondents, 31.5% had shared syringes at least once in the previous 6 months and 55.2% reported sharing injection paraphernalia (spoons, water, filters). A higher risk of syringe sharing was found among IDUs who injected daily (OR = 1.5), injected cocaine (OR = 1.6), had less than half their supply of syringes from a free source (OR = 2.5), had an IDU sexual partner (OR = 1.8) or who reported indirect sharing (OR = 4.1). A higher risk of indirect sharing was found in respondents who had an illegal source of income (OR = 1.5), injected daily (OR = 1, 5), injected cocaine (OR = 1.4), reported sharing syringes (OR = 3.9), or who reported a previous overdose (OR = 1.5).
Conclusions: Despite the widespread use of harm reduction programs in Catalonia, a significant proportion of IDUs continue to practise injection-related risk behaviors. Further reductions in risk behaviors could be achieved by improving access to all sterile injecting equipment, especially among cocaine injectors and IDUs who inject frequently, and by including IDU sexual partners within the current network of harm reduction centers. |
| dc.language.iso | spa |
| dc.publisher | Elsevier España |
| dc.relation.ispartofseries | Gaceta Sanitaria;26(1) |
| dc.rights | Attribution-NonCommercial-ShareAlike 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ |
| dc.source | Scientia |
| dc.subject | Drogoaddicció - Estudi de casos |
| dc.subject | Centres per a drogoaddictes - Catalunya |
| dc.subject.mesh | Harm Reduction |
| dc.subject.mesh | Drug Users |
| dc.subject.mesh | Catalonia |
| dc.title | Perfil de los usuarios de drogas por vía parenteral que mantienen conductas de riesgo relacionadas con la inyección en Cataluña |
| dc.title.alternative | Characteristics of intravenous drug users who share injection equipment in Catalonia (Spain) |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1016/j.gaceta.2011.07.022 |
| dc.subject.decs | reducción de daños |
| dc.subject.decs | consumidores de drogas |
| dc.subject.decs | Cataluña |
| dc.relation.publishversion | https://doi.org/10.1016/j.gaceta.2011.07.022 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.authoraffiliation | [Folch C] Centre d’Estudis Epidemiològics sobre les ITS i Sida a Catalunya (CEEISCAT), Institut Català d'Oncologia (ICO), Badalona, Spain. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Programa de Doctorat en Salut Pública i Metodologia de la Recerca Biomèdica, Departament de Pediatria, d’Obstetrícia i Ginecologia i de Medicina Preventiva, Universitat Autònoma de Barcelona, Barcelona, Spain. [Casabona J] Centre d’Estudis Epidemiològics sobre les ITS i Sida a Catalunya (CEEISCAT), Institut Català d'Oncologia (ICO), Badalona, Spain. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Programa de Doctorat en Salut Pública i Metodologia de la Recerca Biomèdica, Departament de Pediatria, d’Obstetrícia i Ginecologia i de Medicina Preventiva, Universitat Autònoma de Barcelona, Barcelona, Spain. Departament de Pediatria, d’Obstetrícia i Ginecologia i de Medicina Preventiva, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain. [Brugal MA] . Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Agència de Salut Pública de Barcelona, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. [Majó X] Subdirecció General de Drogodependències, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. [Meroño M] Fundació Àmbit Prevenció, Barcelona, Spain. [Espelt A] Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Agència de Salut Pública de Barcelona, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. Departament de Psicobiologia i Metodología de les Ciències de la Salut, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain. [González V] Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Servicio de Microbiología, Hospital Universitari Germans Trias i Pujol, Badalona, Spain |
| dc.identifier.pmid | 22088906 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |